Ekso Bionics Holdings Inc (EKSO) — Cash Flow-to-Debt Ratio
Ekso Bionics Holdings Inc (EKSO) has a Cash Flow-to-Debt Ratio of -0.15x as of March 2026, meaning its operating cash flow of $-2.12 Million could theoretically repay 0% of its total liabilities ($13.93 Million) in one year. See Ekso Bionics Holdings Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ekso Bionics Holdings Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Ekso Bionics Holdings Inc across 14 annual periods. For the full cash flow conversion analysis, see EKSO cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Ekso Bionics Holdings Inc (2012–2025)
Year-by-year debt coverage analysis for Ekso Bionics Holdings Inc. Check Ekso Bionics Holdings Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.06x | $-11.80 Million | $11.08 Million | ▼ -50.8% |
| 2024 | -0.71x | $-9.85 Million | $13.95 Million | ▲ +4.5% |
| 2023 | -0.74x | $-12.05 Million | $16.31 Million | ▲ +22.2% |
| 2022 | -0.95x | $-14.69 Million | $15.46 Million | ▼ -1.7% |
| 2021 | -0.93x | $-11.16 Million | $11.95 Million | ▼ -72.4% |
| 2020 | -0.54x | $-8.76 Million | $16.16 Million | ▲ +48.1% |
| 2019 | -1.04x | $-15.77 Million | $15.12 Million | ▲ +29.7% |
| 2018 | -1.48x | $-22.16 Million | $14.93 Million | ▲ +21.1% |
| 2017 | -1.88x | $-31.23 Million | $16.60 Million | ▼ -34.7% |
| 2016 | -1.40x | $-25.00 Million | $17.89 Million | ▼ -78.9% |
| 2015 | -0.78x | $-18.27 Million | $23.39 Million | ▲ +44.4% |
| 2014 | -1.41x | $-15.01 Million | $10.67 Million | ▼ -65.6% |
| 2013 | -0.85x | $-11.99K | $14.12K | ▲ +0.0% |
| 2012 | -0.85x | $-11.99K | $14.12K | — |